042520.KQ - HansBiomed Corporation

KOSDAQ - KOSDAQ Delayed Price. Currency in KRW
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue9/30/20189/30/20179/30/20169/30/2015
Total Revenue51,745,897.3439,057,689.4329,047,900.7223,428,387.65
Cost of Revenue24,469,508.4620,771,676.3815,664,578.1812,763,461.45
Gross Profit27,276,388.8818,286,013.0513,383,322.5410,664,926.2
Operating Expenses
Research Development1,147,171777,061176,672368,536
Selling General and Administrative15,004,694.17,300,686.546,928,450.275,016,266.88
Non Recurring----
Others367,806204,424162,326217,849
Total Operating Expenses41,437,778.5629,597,511.9223,060,188.4518,370,347.33
Operating Income or Loss10,308,118.789,460,177.515,987,712.275,058,040.32
Income from Continuing Operations
Total Other Income/Expenses Net-5,009,873.8475,948.86-465,561.9462,575.81
Earnings Before Interest and Taxes10,308,118.789,460,177.515,987,712.275,058,040.32
Interest Expense-338,550-248,331-248,331-6,136
Income Before Tax5,298,244.989,936,126.375,522,150.375,520,616.13
Income Tax Expense351,569.351,796,163.67750,191.43611,177.71
Minority Interest4,294,044.61,293,443.82694,347.85694,347.85
Net Income From Continuing Ops4,946,675.638,139,962.74,771,958.944,909,438.42
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income4,017,444.447,828,067.694,625,144.614,909,438.42
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares4,017,444.447,828,067.694,625,144.614,909,438.42